BIRC5 and cancer: Positively-charged ARP-F could absorb negatively charged pCas9-surv, a Cas9 plasmid that targets and knocks out the survivin (an apoptosis inhibitor overexpressed by cancer cells) gene, to form stable nanocomplexes through electrostatic interactions.